Low-flow aortic stenosis and preserved left ventricular ejection fraction by LANCELLOTTI, Patrizio & KOU, Seisyou
REVIEW ARTICLE
Low-flow aortic stenosis and preserved left ventricular
ejection fraction
Patrizio Lancellotti • Kou Seisyou
Received: 30 September 2013 / Revised: 28 November 2013 / Accepted: 2 December 2013 / Published online: 17 December 2013
 Japanese Society of Echocardiography 2013
Abstract Valvular aortic stenosis (AS) is the most frequent
valvular disease in developed countries. Treatment decisions
in AS are mainly based upon the symptomatic status of the
patient and the severity of AS. Doppler echocardiography
represents the standard tool for detecting and assessing the
severity of the disease. Under the same denomination of
severe AS [aortic valve area (AVA) \ 1 cm2], several enti-
ties might be identified that differ in terms of trans-valvular
flow rates and pressure gradients development. From a clin-
ical standpoint, severe AS (AVA \ 1 cm2) can be subdi-
vided into 4 flow-gradient patterns: normal flow/low gradient
(NF/LG), normal flow/high gradient (NF/HG), low flow/high
gradient (LF/HG) and low flow/low gradient (LF/LG). The
most commonly described entity is the paradoxical low-flow,
low-gradient severe AS state, in which the stroke volume is
unexpectedly reduced, despite preserved left ventricular (LV)
ejection fraction. In daily practice, misdiagnosing this clini-
cal condition might lead to an inappropriate timing of follow-
up with an unnecessary delay of aortic valve replacement
(AVR), which may, in turn, have a negative impact on patient
outcome.
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Introduction
Valvular aortic stenosis (AS) is the most frequent valvular
disease in developed countries. Treatment decisions in AS
are mainly based upon the symptomatic status of the
patient and the severity of AS. Doppler echocardiography
represents the standard tool for detecting and assessing the
severity of the disease [1]. Severe AS is usually defined on
the basis of an aortic valve area (AVA) \1 cm2, a mean
trans-aortic pressure gradient C40 mmHg and a peak aortic
jet velocity [4 m/s [2]. However, discrepancies are fre-
quently observed between the mean gradient and the valve
area in a single patient [3]. In fact, given that gradients are
a squared function of flow, even a modest decrease in flow
may lead to an important reduction in gradient, even if the
stenosis is very severe. These discrepancies are, thus, easy
to understand in patients with low cardiac output secondary
to reduced left ventricular (LV) ejection fraction, but also
may occur in patients with apparently preserved LV ejec-
tion fraction [4]. The most commonly described entity is
the paradoxical low-flow, low-gradient severe AS state, in
which the stroke volume is unexpectedly reduced, despite
preserved LV ejection fraction. In daily practice, misdi-
agnosing this clinical condition might lead to an inappro-
priate timing of follow-up with an unnecessary delay of
aortic valve replacement (AVR), which may, in turn, have
a negative impact on patient outcome [5–7].
New look into AS grading severity
Under the same denomination of severe AS
(AVA \ 1 cm2), several entities might be identified that
differ in terms of trans-valvular flow rates and pressure
gradients development [8–11]. From a clinical standpoint,
severe AS (AVA \ 1 cm2) can be subdivided into 4 flow-
gradient patterns: normal flow/low gradient (NF/LG), nor-
mal flow/high gradient (NF/HG), low flow/high gradient
(LF/HG) and low flow/low gradient (LF/LG). LF is defined
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as an indexed LV stroke volume \35 ml/m2 and LG as a
mean trans-aortic pressure gradient \40 mmHg [12]
(Table 1). The NF/LG pattern is observed in 31–38 % of
patients and seems to identify a group of patients with a less
severe degree of AS—inherent inconsistency contained in
the guidelines—or who has been exposed to the disease for a
shorter period of time. The NF/HG pattern represents the
most prevalent entity (39–72 %) and is fully consistent with
the criteria proposed by the guidelines [4, 5, 12]. The LF/HG
pattern accounts for 8 % of patients with severe AS [4, 12].
An indexed LV stroke volume \35 ml/m2 in spite of pre-
served LV ejection fraction characterises this group. The
prevalence of the LF/LG pattern, namely paradoxical LF/
LG AS, seems to be lower than that initially reported. The
LF/LG entity accounts for 7 % in asymptomatic patients and
up to 15–35 % in symptomatic patients [4–6, 12, 13]. This
pattern represents a challenging clinical entity that shares
many pathophysiological and clinical similarities with heart
failure and preserved LV ejection fraction.
Pathophysiology
The present 4 flow-gradient patterns hold different phys-
iopathology and cardiac adaptation. The NF/LG entity is
characterised by a mild degree of LV remodelling, a pre-
served LV longitudinal myocardial function, resulting in
lower brain natriuretic peptide (BNP) level and Monin’s
risk score [score = (peak velocity (m/s) 9 2) ? (natural
logarithm of B-type natriuretic peptide 9 1.5) ? 1.5 (if
female sex)], normal or mildly elevated global LV after-
load, as estimated by the valvulo-arterial impedance (Zva),
and less severe AS [12, 14]. When compared with the NF/
LG group, although the LV longitudinal function is pre-
served, the global LV afterload, the BNP release and the
degree of LV hypertrophy are higher in the NF/HG group.
Furthermore, patients with NF/HG seem to have more
severe AS, suggesting a longer exposition to this progres-
sive disease. The LF/HG pattern is characterised by a high
BNP level and Monin’s risk score, an increased global LV
afterload and a significant reduction in LV longitudinal
function [13]. Of note, the LV ejection fraction is a crude
estimate of the LV systolic function. The LV ejection
fraction is influenced by both intrinsic myocardial function
and the LV cavity geometry. Hence, for a similar extent of
intrinsic myocardial shortening, the LV ejection fraction
will tend to increase in relation to the extent of LV con-
centric remodelling. The LV ejection fraction may, there-
fore, markedly underestimate the extent of myocardial
impairment in the presence of LV concentric remodelling,
such as is generally the case in AS patients. Hence, what is
normal for a left ventricle with normal geometry may be
abnormal for a left ventricle with concentric remodelling.
Moreover, the reduction in LV output (related to intrinsic
myocardial dysfunction and significant LV remodelling)
may, in turn, result in lower than expected trans-valvular
gradients. The LF/LG pattern is associated with more pro-
nounced LV concentric remodelling, smaller LV cavity,
increased global LV afterload (Zva), intrinsic myocardial
dysfunction and more myocardial fibrosis [12, 13, 15]. Of
note, the double load (valvular ? vascular) imposes on the
LV results from outflow obstruction (AS) and reduces
systemic arterial compliance (vascular disease) due to the
concomitant presence of systemic atherosclerosis, hyper-
tension and/or diabetes in these patients. The chronically
increased global LV afterload plays a direct detrimental
effect on the LV systolic function with a progressive
decrease in the LV stroke volume due to a restrictive
physiology—impaired LV filling—because of a smaller LV
cavity size and ongoing intrinsic myocardial impairment.
Assessment of disease severity: pitfalls and differential
diagnosis
The accurate assessment of the haemodynamic severity of
AS is vital. In daily practice, the assessment of AS severity
should integrate the flow-gradient pattern to the classic
measurement of the AVA. As a general rule, a low trans-
valvular gradient (\40 mmHg) or velocity (\4 m/s) does
not exclude the presence of a severe AS in patients with
small AVA and preserved LV ejection fraction. In addition,
a preserved LV ejection fraction ([50 %) does not exclude
the presence of myocardial systolic dysfunction and low
trans-valvular flow in AS. Potential causes of discordance
between AVA and gradient in patients with preserved LV
ejection fraction include: (a) measurement errors; (b) small
body size; (c) paradoxical low-flow AS; and (d) inconsis-
tent grading related to intrinsic discrepancies in guidelines
criteria [4, 6, 7, 10, 11]. First of all, patients with small
body size and LV dimensions may exhibit a lower trans-
valvular pressure gradient because of a lower, albeit nor-
mal, stroke volume. Secondly, the stroke volume and,
Table 1 New aortic stenosis (AS) grading classification
Normal flow/high gradient Normal flow/low gradient
AVA \0.6 cm2/m2 AVA \0.6 cm2/m2
SVi C35 ml/m2 SVi C35 ml/m2
Mean gradient C40 mmHg Mean gradient \40 mmHg
Low flow/high gradient Low flow/low gradient
AVA \0.6 cm2/m2 AVA \0.6 cm2/m2
SVi \35 ml/m2 SVi \35 ml/m2
Mean gradient C40 mmHg Mean gradient \40 mmHg
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therefore, the AVA may be underestimated because of
underestimation of the LV outflow tract and/or misplace-
ment of the pulsed-wave Doppler sample volume. Several
methods can be used to corroborate the Doppler echocar-
diographic measurements of stroke volume and AVA. For
example, in the absence of significant mitral regurgitation,
the stroke volume can easily be estimated by Simpson’s
method (volumetric method to measure LV ejection frac-
tions and volumes). If the stroke volume measured by these
independent methods is consistent with the stroke volume
measured in the LV outflow tract, one can be reassured
about the accuracy of the measurement of the stroke vol-
ume. Third, paradoxical LF/LG represents a new entity in
which the LF state results from both LV concentric
remodelling and reduced subendocardial longitudinal
function. This outlines the absence of the erroneous esti-
mation of AS severity. Fourth, in some cases, discrepancy
in the gradient–valve area relationship may be related to
inconsistencies in current guidelines. A harmonisation of
the definition of severe AS may reclassify some of these
patients with ‘‘severe’’ AS as ‘‘moderate’’ AS. When one
combines the current prospective clinical data with earlier
haemodynamic echo and invasive data, it seems that a
gradient of 40 mmHg fits more with a valve area of
0.8 cm2, whereas a valve area of 1 cm2 relates to a mean
gradient of 26 mmHg [3, 6, 16]. Furthermore, when there is
a discordance between the valve area (in the severe range)
and the gradient (in the moderate range) in patients with
preserved LV ejection fraction, a more comprehensive
Doppler echocardiographic evaluation and, potentially,
other diagnostic tests (BNP, calcium score by multislice
computed tomography, exercise/dobutamine stress echo-
cardiography) may be required to confirm disease severity
and guide therapeutic management [17, 18]. Hence, a
meticulous differential diagnosis is of utmost importance
when a diagnosis of LF/LG AS is being made (Table 2).
Clinical outcome and management
Patients with NF/LG AS classically have no or minimal
subendocardial dysfunction and a relatively preserved
outcome [12, 19, 20]. In this NF/LG category, indication
for AVR should be restricted to patients in whom symp-
toms can clearly be attributed to AS. In the NF/HG cate-
gory, AVR (surgical or percutaneous) is the only therapy to
significantly improve both survival and symptoms. When
asymptomatic, individual risk stratification can help iden-
tify patients who may benefit from early surgery. In the
other categories, the LF state represents a witness of
intrinsic myocardial dysfunction and a more advanced
disease process (Table 3). The outcome of the LF/HG
patients is nearly identical to patients with NF/HG. When
symptomatic, these patients have a better survival if treated
surgically. Hence, symptomatic patients with LF/HG
should benefit from prompt AVR. When asymptomatic,
individual risk stratification should also be encouraged.
Stress echocardiography may be of interest by unmasking
patients with limited valve compliance and/or exhausted
LV contractile reserve [17, 18]. Paradoxical LF/LG con-
veys a poor outcome, even in asymptomatic patients. In
asymptomatic patients, we have shown that the likelihood
of remaining alive without AVR at 3 years was 5-fold
lower than for the NF/LG pattern and 4.3-fold higher than
in the NF/HG group [12]. This clinical entity is often
misdiagnosed, which may lead to an underestimation of AS
severity and, thereby, to underutilisation or inappropriate
delay of surgery [19]. It is important to recognise this entity
in order not to deny surgery to a symptomatic patient with
small AVA and LG. Indeed, in this category, though the
benefit of surgery is not proven, AVR may probably be
beneficial in selected symptomatic patients [7, 20–23]. Of
note, the current 2006 American College of Cardiology/
Table 2 Stepwise approach to the differential diagnosis of low flow/
low gradient (LF/LG) aortic stenosis (AS) and preserved left ven-
tricular (LV) ejection fraction ([50 %)
1) Index AVA to BSA, particularly in small patients
(\0.6 cm2/m2)
2) Search for other findings of LF/LG AS
a. Doppler velocity ratio \0.25
b. Calculate the valulo-arterial impedance (Zva [4.5
mmHg/ml/m2)
c. Measure the global longitudinal strain (GLS \16 %)
d. Evaluate the relative wall thickness ([0.5)
e. Confirm the small LV cavity size (end-diastolic volume index
\55 ml/m2)
3) Validate stroke volume measurement
a. Corroborate the LV ejection fraction obtained by Dumesnil’s
method (Doppler-derived stroke volume/end-diastolic volume
derived from Teichholz’s formula) and Simpson’s method [9]
b. Use other imaging modalities to assess stroke volume
i. 3D echocardiography
ii. Cardiac magnetic resonance
4) Measure BNP level (increased value)
5) Measure the calcium score by multislice computed tomography
(increased value)
6) Evaluate the changes in pressure gradients and AVA during
stress echocardiography (increase in pressure gradient in relation
to the increase in stroke volume without significant change in
AVA)
7) Invasive measurements
AVA = aortic valve area; Zva = sum of the systolic arterial
pressure and the mean trans-valvular pressure gradient divided
by the stroke volume index, it represents the global load
(valvular ? vascular) imposed on the LV and identifies poor
outcome in severe AS patients
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American Heart Association (ACC/AHA) guidelines do
not contain any specific recommendations for the man-
agement of LF/LG AS [2]. Conversely, in the recent 2012
European Society of Cardiology/European Association for
Cardio-Thoracic Surgery (ESC/EACTS) guidelines, AVR
should be considered (class IIa) in symptomatic patients
with LF/LG AS and preserved LV ejection fraction only
after careful confirmation of severe AS [24].
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